ForeseeHome™ - AMD Monitoring Program

Peer Reviewed Publications


Randomized trial of the ForeseeHome monitoring device for early detection of neovascular age-related macular degeneration. The HOme Monitoring of the Eye (HOME) study design — HOME Study report number 1
Chew E, Clemons T, Bressler S, Elman M, Danis R, Domalpally A, Heier J, Kim J, Garfinkel R
Contemp Clin Trials. 2014;37(2):294-300

Randomized Trial of a Home Monitoring System for Early Detection of Choroidal Neovascularization Home Monitoring of the Eye (HOME) Study
Chew E, Clemons T, Bressler S, Elman M, Danis R, Domalpally A, Heier J, Kim J, Garfinkel R
Ophthalmology 2014; 121:535-544

Toward Earlier Detection of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Loewenstein A, Ferencz JR, Lang Y, Yeshurun I, Pollack A, Siegal R, Lifshitz T, Karp J, Roth D, Bronner G, Brown J, Mansour S, Friedman S, Michels M, Johnston R, Rapp M, Havilio M, Rafaeli O, Manor Y
Retina 2010; 30:1058-1064  

Macular Diseases: Moving the Battlefield to the Patient's Home
Loewenstein A
Retina 2011; 31: 1445-1448.


Preferential Hyperacuity Perimetry (PHP)

Preferential Hyperacuity Perimeter and Prognostic actors for Metamorphopsia after Idiopathic Epiretinal Membrane Surgery
Bae SH, Kim D, Park TK, Han JR, Kim H, Nam W
AJO 2013; 155(1): 109-117

Preferential Hyperacuity Perimeter as a Functional Tool for Monitoring Exudative Age-Related Macular Degeneration in Patients Treated by Intravitreal Ranibizumab
Querques G, Querques L, Rafaeli O, Canoui-Poitrine F, Bandello F, Souied E
IOVS 2011; 52:7012-7018 

Functional and Morphologic Benefits in Early Detection of Neovascular Age-Related Macular Degeneration Using the Preferential Hyperacuity Perimeter
Lai Y, Grattan J, Shi Y, Young G, Muldrew A, Chakravarthy U
Retina 2011; 31(8):1620-1626  

Preferential Hyperacuity Perimeter in Best Vitelliform Macular Dystrophy
Querques G, Atmani K, Bouzitou-Mfoumou R, Leveziel N, Massamba N, Souied EH
Retina 2011; 31: 959-966

Long Term Monitoring of Age-Related Macular Degeneration with Preferential Hyperacuity Perimetry
Stur M, Manor Y
OSLI 2010: 598-606

Preferential Hyperacuity Perimeter in Assessing Responsiveness to Ranibizumab Therapy for Exudative Age-related Macular Degeneration
Querques G, Berboucha E, Leveziel N, Pece A, Souied E
British Journal of Ophthalmology 2010; 95: 986-991

Distortion Maps from Preferential Hyperacuity Perimetry are Helpful in Monitoring Functional Response to Lucentis Therapy
Das R, Shi Y, Silvestri G, Chakravarthy U
Retina 2009; 29(7): 1013-1018

Preferential Hyperacuity Perimetry to Detect Hydroxychloroquine Retinal Toxicity
Anderson C, Pahk P, Blaha G, Spindel G,  Alster Y, Rafaeli O, Marx J
Retina 2009; 29: 1188-1192

Preferential Hyperacuity Perimetry for Detecting Choroidal Neovascularization Study
Alster Y, Bressler N, Bressler S, Brimacombe J, Crompton R, Duh Y, Gabel V, Heier J, Ip M, Loewenstein A, Packo K, Stur M, Toaff T
Ophthalmology 2005; 112: 1758-1765

Results of a Multicenter Clinical Trial to Evaluate the Preferential Hyperacuity Perimeter for Detection of Age-Related Macular Degeneration
Shachat A, Bressler N, Bressler S, Cooney M, Goldstein M, Loewenstein A, Barak A, Pollack A, Bukelman A, Katz H, Springer A, Alster Y, Rafaeli O, Malach R
Retina 2005; 25: 296-303


Other Topics

The Significance of Early Detection of Age-Related Macular Degeneration
Loewenstein A
Retina 2007; 27: 873-878

Replacing the Amsler Grid, A New Method for Monitoring Patients with Age-Related Macular Degeneration Loewenstein A, Malach R, Goldstein M, Leibovitch I, Barak A, Baruch E, Alster Y, Rafaeli O, Avni I, Yassur Y Ophthalmology 2003; 110: 966-970   


Other Publications

Monitoring AMD with the ForeseeHome
Retina Today, Jan/Feb 2011

Monitoring Conversion from Non-neovascular to Neovascular AMD and Identifying Patients at Risk
Retinal Physician, October 2010

Home Testing Device May Help Monitor Patients at Risk for CNV Development
Ocular Surgery News, September 2010